HSP90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
HSP90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression ; volume:14 ; number:1 ; day:29 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (29.9.2024), 1-11, 12.2024
- Urheber
-
Hong, Lingjia
Tanaka, Manami
Yasui, Masato
Hara-Chikuma, Mariko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-73394-9
- URN
-
urn:nbn:de:101:1-2412152102096.438746524605
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hong, Lingjia
- Tanaka, Manami
- Yasui, Masato
- Hara-Chikuma, Mariko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
Overexpression of SLAP2 inhibits triple-negative breast cancer progression by promoting macrophage M1-type polarization
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase
Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer
HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk
IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells
MicroRNA signatures in triple-negative breast cancer
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
Overexpression of SLAP2 inhibits triple-negative breast cancer progression by promoting macrophage M1-type polarization
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase
Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer
HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk
IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells
MicroRNA signatures in triple-negative breast cancer
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
Overexpression of SLAP2 inhibits triple-negative breast cancer progression by promoting macrophage M1-type polarization
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase
Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer
HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk
IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells